Cancer Cause and Prevention Research in North Carolina
Cancer Cause and Prevention Research (93.393) awarded $149 million to recipients in North Carolina in 116 grants from fiscal 2021 to 2025, 4.1% of the program's national total. University of North Carolina at Chapel Hill received the most, $76.1 million.
- Awarded in North Carolina$149 million
- Awards116
- Share of the program4.1%
- Rank among states7th of 48
- National total$3.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 50 | $25.2 million |
| FY 2022 | 56 | $27.3 million |
| FY 2023 | 64 | $30.3 million |
| FY 2024 | 62 | $30.6 million |
| FY 2025 | 61 | $35.2 million |
Recipients in North Carolina
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| University of North Carolina at Chapel Hill | Colleges and universities | 49 | $76.1 million |
| Duke University | Colleges and universities | 37 | $40.5 million |
| Wake Forest University Health Sciences | Colleges and universities | 19 | $25.7 million |
| Digital Health Navigation Solutions, Inc. | Small businesses | 1 | $2.4 million |
| University of North Carolina at Charlotte | Colleges and universities | 5 | $2.3 million |
| North Carolina State University | Colleges and universities | 4 | $1.2 million |
| East Carolina University | Colleges and universities | 1 | $630,395 |
Open opportunities under this program
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 60 on the program page
Questions people ask
How much Cancer Cause and Prevention Research money goes to North Carolina?
$149 million from fiscal 2021 to 2025, across 116 awards. North Carolina ranks 7th of 48 states and territories for this program.
Who receives Cancer Cause and Prevention Research money in North Carolina?
The largest recipient is University of North Carolina at Chapel Hill, with $76.1 million in 49 awards. Next are Duke University and Wake Forest University Health Sciences.
Can organizations in North Carolina apply now?
Yes, 60 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Cause and Prevention Research in other states
Other large programs in North Carolina
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Children's Health Insurance Program
- USAID Foreign Assistance for Programs Overseas
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Child Care and Development Block Grant
- Title I Grants to Local Educational Agencies
- Special Education Grants to States